Back
Maze Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
6
MAZE
Maze Therapeutics, Inc.
Last Price:
$28.72
Seasonality Move:
-7.25%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MAZE is experiencing slight selling pressure.
Maze Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.43 | Sell |
| 20-day SMA: | 42.47 | Sell |
| 50-day SMA: | 44.44 | Sell |
| 200-day SMA: | 30.67 | Sell |
| 8-day EMA: | 32.93 | Sell |
| 20-day EMA: | 38.97 | Sell |
| 50-day EMA: | 41.93 | Sell |
| 200-day EMA: | 32.28 | Sell |
Maze Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.67 | Sell |
| Relative Strength Index (14 RSI): | 24.83 | Sell |
| Chaikin Money Flow: | -178122 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34.66 - 51.46) | Sell |
| Bollinger Bands (100): | (35.7 - 47.36) | Sell |
Maze Therapeutics, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Maze Therapeutics, Inc. Stock
Is Maze Therapeutics, Inc. Stock a Buy?
-
Maze Therapeutics, Inc. share price is 28.71 while MAZE 8-day simple moving average is 32.43, which is a Sell signal.
-
The stock price of MAZE is 28.71 while Maze Therapeutics, Inc. 20-day SMA is 42.47, which makes it a Sell.
-
Maze Therapeutics, Inc. 50-day simple moving average is 44.44 while MAZE share price is 28.71, making it a Sell technically.
-
MAZE stock price is 28.71 and Maze Therapeutics, Inc. 200-day simple moving average is 30.67, creating a Sell signal.
MAZE Technical Analysis vs Fundamental Analysis
Sell
6
Maze Therapeutics, Inc. (MAZE)
is a Sell
Is Maze Therapeutics, Inc. a Buy or a Sell?
-
Maze Therapeutics, Inc. stock is rated a SellThe current Maze Therapeutics, Inc. [MAZE] share price is $28.71. The Score for MAZE is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
Maze Therapeutics, Inc. Stock Info
Market Cap:
1.4B
Price in USD:
28.71
Share Volume:
780.3K
Maze Therapeutics, Inc. 52-Week Range
52-Week High:
53.65
52-Week Low:
6.71
Sell
6
Maze Therapeutics, Inc. (MAZE)
is a Sell
Maze Therapeutics, Inc. Share Price Forecast
-
What is the Maze Therapeutics, Inc. stock price today?The Maze Therapeutics, Inc. stock price is 28.71 USD today.
-
Will MAZE stock go up or go down?Maze Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Maze Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Maze Therapeutics, Inc. is overvalued.
Is Maze Therapeutics, Inc. Stock a Buy?
-
Maze Therapeutics, Inc. share price is 28.71 while MAZE 8-day exponential moving average is 32.93, which is a Sell signal.
-
The stock price of MAZE is 28.71 while Maze Therapeutics, Inc. 20-day EMA is 38.97, which makes it a Sell.
-
Maze Therapeutics, Inc. 50-day exponential moving average is 41.93 while MAZE share price is 28.71, making it a Sell technically.
-
MAZE stock price is 28.71 and Maze Therapeutics, Inc. 200-day simple moving average is 32.28, creating a Sell signal.
Fundamental Analysis of Maze Therapeutics, Inc.
Is Maze Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.28 per share, an increase this year of $0.22 per share, and a decrease next year of $0.79 per share.
Technical Analysis of Maze Therapeutics, Inc.
Should I short Maze Therapeutics, Inc. stock?
-
MAZE Moving Average Covergence Divergence (MACD) indicator is -4.67, suggesting Maze Therapeutics, Inc. is a Sell
-
Maze Therapeutics, Inc. Relative Strength Index (RSI) is 24.83, which suggest Maze Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Maze Therapeutics, Inc. is (34.66 - 51.46), which suggest Maze Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Maze Therapeutics, Inc. is (35.7 - 47.36), which suggest Maze Therapeutics, Inc. is a Sell
* Maze Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.